Global and United States In-Silico Drug Discovery Market Report & Forecast 2022-2028

In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
Market Analysis and Insights: Global and United States In-Silico Drug Discovery Market
This report focuses on global and United States In-Silico Drug Discovery market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global In-Silico Drug Discovery market size is estimated to be worth US$ 2248.1 million in 2022 and is forecast to a readjusted size of US$ 4413.6 million by 2028 with a CAGR of 11.9% during the review period. Fully considering the economic change by this health crisis, by Type, Software as a Service (Cloud) accounting for % of the In-Silico Drug Discovery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Contract Research Organization was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
Global In-Silico Drug Discovery Scope and Market Size
In-Silico Drug Discovery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global In-Silico Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the In-Silico Drug Discovery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)

Frequently Asked Questions